Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome 1 ☆
Matthew Coates(Pennsylvania State University), Gary M. Mawe(University of Vermont), Michael D. Crowell(Mayo Clinic Hospital), Christine R. Mahoney(University of Vermont), Hagen Blaszyk(University of Vermont), David R. Linden(University of Vermont), Keith A. Sharkey(University of Calgary), Joanna E. Sampson(University of Vermont), Jason Chen(VA Ann Arbor Healthcare System), Michael D. Gershon(Columbia University)
Cited by 772
Related Papers
Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets
|Nature Reviews Gastroenterology & Hepatology|2013|1.1k
Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report
|PEDIATRICS|2010|870
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
|Gastroenterology|2016|696
Review article: roles played by 5‐hydroxytryptamine in the physiology of the bowel
|Alimentary Pharmacology & Therapeutics|1999|460
Activation of neuronal P2X7 receptor–pannexin-1 mediates death of enteric neurons during colitis
|Nature Medicine|2012|444